ABBOTT LABORATORIES - Common Stock (ABT)

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock
Shares outstanding
1,740,239,592
Total 13F shares
1,273,140,330
Share change
+10,884,949
Total reported value
$67,943,393,768
Put/Call ratio
74%
Price per share
$53.36
Number of holders
1,591
Value change
+$614,368,368
Number of buys
617
Number of sells
769

Institutional Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q3 2017

As of 30 Sep 2017, ABBOTT LABORATORIES - Common Stock (ABT) was held by 1,591 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,273,140,330 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Bank of New York Mellon Corp, PRICE T ROWE ASSOCIATES INC /MD/, NORTHERN TRUST CORP, and BANK OF AMERICA CORP /DE/. This page lists 1,592 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.